Patents by Inventor Edward Overstreet

Edward Overstreet has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11338138
    Abstract: According to an embodiment, a system for acquiring ECAP recordings at a later session for a cochlear implant patient is disclosed. The system includes a receiving unit configured to receive, corresponding to an electrode, a stored prior individual value from a plurality of stored prior individual values of ECAP/an ECAP prior growth function, the plurality of stored prior individual values or the ECAP prior growth function being obtained at a previous session. Furthermore, a processing unit configured to process the received prior individual value/ECAP growth function to determine a stimulus signal value corresponding to the received individual value/a selected point on the ECAP prior growth function, instruct a signal delivery unit to provide to the electrode a first stimulus signal comprising a first level that is same or above said stimulus signal value, and determine a resulting ECAP generated in response to said first stimulus signal.
    Type: Grant
    Filed: December 3, 2019
    Date of Patent: May 24, 2022
    Assignee: Oticon Medical A/S
    Inventor: Edward Overstreet
  • Publication number: 20200101282
    Abstract: According to an embodiment, a system for acquiring ECAP recordings at a later session for a cochlear implant patient is disclosed. The system includes a receiving unit configured to receive, corresponding to an electrode, a stored prior individual value from a plurality of stored prior individual values of ECAP/an ECAP prior growth function, the plurality of stored prior individual values or the ECAP prior growth function being obtained at a previous session. Furthermore, a processing unit configured to process the received prior individual value/ECAP growth function to determine a stimulus signal value corresponding to the received individual value/a selected point on the ECAP prior growth function, instruct a signal delivery unit to provide to the electrode a first stimulus signal comprising a first level that is same or above said stimulus signal value, and determine a resulting ECAP generated in response to said first stimulus signal.
    Type: Application
    Filed: December 3, 2019
    Publication date: April 2, 2020
    Applicant: Oticon Medical A/S
    Inventor: Edward OVERSTREET
  • Patent number: 10549089
    Abstract: According to an embodiment, a system for acquiring ECAP recordings at a later session for a cochlear implant patient is disclosed. The system includes a receiving unit configured to receive, corresponding to an electrode, a stored prior individual value from a plurality of stored prior individual values of ECAP/an ECAP prior growth function, the plurality of stored prior individual values or the ECAP prior growth function being obtained at a previous session. Furthermore, a processing unit configured to process the received prior individual value/ECAP growth function to determine a stimulus signal value corresponding to the received individual value/a selected point on the ECAP prior growth function, instruct a signal delivery unit to provide to the electrode a first stimulus signal comprising a first level that is same or above said stimulus signal value, and determine a resulting ECAP generated in response to said first stimulus signal.
    Type: Grant
    Filed: December 16, 2016
    Date of Patent: February 4, 2020
    Assignee: OTICON MEDICAL A/S
    Inventor: Edward Overstreet
  • Publication number: 20170173332
    Abstract: According to an embodiment, a system for acquiring ECAP recordings at a later session for a cochlear implant patient is disclosed. The system includes a receiving unit configured to receive, corresponding to an electrode, a stored prior individual value from a plurality of stored prior individual values of ECAP /an ECAP prior growth function, the plurality of stored prior individual values or the ECAP prior growth function being obtained at a previous session. Furthermore, a processing unit configured to process the received prior individual value /ECAP growth function to determine a stimulus signal value corresponding to the received individual value /a selected point on the ECAP prior growth function, instruct a signal delivery unit to provide to the electrode a first stimulus signal comprising a first level that is same or above said stimulus signal value, and determine a resulting ECAP generated in response to said first stimulus signal.
    Type: Application
    Filed: December 16, 2016
    Publication date: June 22, 2017
    Applicant: Oticon Medical A/S
    Inventor: Edward OVERSTREET
  • Patent number: 8498714
    Abstract: An exemplary method of conveying fine structure information to a cochlear implant patient includes dividing an audio signal into a plurality of analysis channels, generating electrical stimulation in accordance with the information contained within each of the analysis channels, applying the electrical stimulation to at least one stimulation site within a patient via a plurality of stimulation channels, and at least partially isolating one of the stimulation channels from a rest of the stimulation channels, wherein fine structure information is conveyed to the patient via the isolated stimulation channel. Corresponding methods and systems are also disclosed.
    Type: Grant
    Filed: September 15, 2009
    Date of Patent: July 30, 2013
    Assignee: Advanced Bionics, LLC
    Inventors: Leonid M. Litvak, Aniket Saoji, Anthony J. Spahr, Edward Overstreet
  • Patent number: 8409303
    Abstract: In the processes for treating municipal sewage and storm water containing biosolids to discharge standards, biosolids, even after dewatering, contain typically about 80% water bound in the dead cells of the biosolids, which gives biosolids a negative heating value. It can be incinerated only at the expense of purchased fuel. Biosolids are heated to a temperature at which their cell structure is destroyed and, preferably, at which carbon dioxide is split off to lower the oxygen content of the biosolids. The resulting char is not hydrophilic, and it can be efficiently dewatered and/or dried and is a viable renewable fuel. This renewable fuel can be supplemented by also charging conventional biomass (yard and crop waste, etc.) in the same or in parallel facilities. Similarly, non-renewable hydrophilic fuels can be so processed in conjunction with the processing of biosolids to further augment the energy supply.
    Type: Grant
    Filed: February 11, 2011
    Date of Patent: April 2, 2013
    Assignee: SGC Advisors, LLC
    Inventors: Norman L. Dickinson, Kevin M. Bolin, Edward Overstreet, Brian Dooley
  • Publication number: 20110192074
    Abstract: In the processes for treating municipal sewage and storm water containing biosolids to discharge standards, biosolids, even after dewatering, contain typically about 80% water bound in the dead cells of the biosolids, which gives biosolids a negative heating value. It can be incinerated only at the expense of purchased fuel. Biosolids are heated to a temperature at which their cell structure is destroyed and, preferably, at which carbon dioxide is split off to lower the oxygen content of the biosolids. The resulting char is not hydrophilic, and it can be efficiently dewatered and/or dried and is a viable renewable fuel. This renewable fuel can be supplemented by also charging conventional biomass (yard and crop waste, etc.) in the same or in parallel facilities. Similarly, non-renewable hydrophilic fuels can be so processed in conjunction with the processing of biosolids to further augment the energy supply.
    Type: Application
    Filed: February 11, 2011
    Publication date: August 11, 2011
    Applicant: ENERTECH ENVIRONMENTAL, INC.
    Inventors: Norman L. Dickinson, Kevin M. Bolin, Edward Overstreet, Brian Dooley
  • Patent number: 7909895
    Abstract: In the processes for treating municipal sewage and storm water containing biosolids to discharge standards, biosolids, even after dewatering, contain typically about 80% water bound in the dead cells of the biosolids, which gives biosolids a negative heating value. It can be incinerated only at the expense of purchased fuel. Biosolids are heated to a temperature at which their cell structure is destroyed and, preferably, at which carbon dioxide is split off to lower the oxygen content of the biosolids. The resulting char is not hydrophilic, and it can be efficiently dewatered and/or dried and is a viable renewable fuel. This renewable fuel can be supplemented by also charging conventional biomass (yard and crop waste, etc.) in the same or in parallel facilities. Similarly, non-renewable hydrophilic fuels can be so processed in conjunction with the processing of biosolids to further augment the energy supply.
    Type: Grant
    Filed: November 7, 2005
    Date of Patent: March 22, 2011
    Assignee: EnerTech Environmental, Inc.
    Inventors: Norman L. Dickinson, Kevin M. Bolin, Edward Overstreet, Brian Dooley
  • Publication number: 20080021551
    Abstract: Errors in pitch (frequency) allocation within a cochlear implant are corrected in order to provide a significant and profound improvement in the quality of sound perceived by the cochlear implant user. In one embodiment, the user is stimulated with a reference signal, e.g., the tone “A” (440 Hz) and then the user is stimulated with a probe signal, separated from the reference signal by an octave, e.g., high “A” (880 Hz). The user adjusts the location where the probe signal is applied, using current steering, until the pitch of the probe signal, as perceived by the user, matches the pitch of the reference signal, as perceived by the user. In this manner, the user maps frequencies to stimulation locations in order to tune his or her implant system to his or her unique cochlea.
    Type: Application
    Filed: July 31, 2007
    Publication date: January 24, 2008
    Applicant: ADVANCED BIONICS CORPORATION
    Inventors: Edward Overstreet, Leonid Litvak, William Harrison
  • Publication number: 20070282395
    Abstract: A system and method uses an electrical stimulator to stimulate the auditory system with a relatively simple signal that contains temporally challenging information in order to preserve neuronal survival and plasticity of the auditory system, and also to preserve residual hearing. The stimulation provided need not be continuous, but may be provided only during limited periods of time each day, or only on selected days. The system or method is particularly suited for very young children who acquire hearing impairment or deafness early in life and who may not yet be ready for a cochlear implant. The invention requires only minimal surgical intervention, if any, and may be carried out without the need for intra-cochlear electrodes. Under special circumstances, the invention may also be used with older children or adults with a hearing impairment or deafness.
    Type: Application
    Filed: September 30, 2004
    Publication date: December 6, 2007
    Inventors: Albert Maltan, Edward Overstreet, Janusz Kuzma
  • Publication number: 20070282396
    Abstract: An implantable microstimulator, or equivalent neural stimulator, generates a relatively simple signal containing temporally challenging information and delivers such signal to the middle or outer portion of the ear contra-lateral to an ear having a cochlear implant of a bilaterally deafened patient. Such stimulation delivered to the contra lateral ear advantageously increases the survival rate of neurons therein, and further helps maintain or extend the plasticity of the higher auditory pathways of the contra-lateral ear, thereby allowing a cochlear implant to be more effectively used in such ear at a later date. The stimulation provided by the microstimulator, or equivalent simple neural stimulator, need not be continuous, but may be provided only during limited periods of time each day, or only on selected days. Further, such stimulation preserves whatever residual hearing may be left in the contra lateral ear.
    Type: Application
    Filed: September 30, 2004
    Publication date: December 6, 2007
    Inventors: Edward Overstreet, Albert Maltan, Janusz Kuzma
  • Publication number: 20070244522
    Abstract: A neurostimulator system (170) stimulates excitable muscle or neural tissue through multiple electrodes (E1, E2, . . . En) fast enough to induce stochastic neural firing, thereby acting to restore “spontaneous” neural activity. The type of stimulation provided by the neurostimulator involves the use of a high rate, e.g., greater than about 2000 Hz, pulsatile stimulation signal generated by a high rate pulse generator (172). The stream of pulses generated by the high rate pulse generator is amplitude modulated in an output driver circuit (176) with control information, provided by a modulation control element (178). Such amplitude-modulated pulsatile stimulation exploits the subtle electro physiological differences between cells comprising excitable tissue in order to desynchronize action potentials within the population of excitable tissue.
    Type: Application
    Filed: June 13, 2007
    Publication date: October 18, 2007
    Applicant: ADVANCED BIONICS CORPORATION
    Inventor: Edward Overstreet
  • Publication number: 20070239226
    Abstract: A neurostimulator system (170) stimulates excitable muscle or neural tissue through multiple electrodes (E1, E2, . . . En) fast enough to induce stochastic neural firing, thereby acting to restore “spontaneous” neural activity. The type of stimulation provided by the neurostimulator involves the use of a high rate, e.g., greater than about 2000 Hz, pulsatile stimulation signal generated by a high rate pulse generator (172). The stream of pulses generated by the high rate pulse generator is amplitude modulated in an output driver circuit (176) with control information, provided by a modulation control element (178). Such amplitude-modulated pulsatile stimulation exploits the subtle electro physiological differences between cells comprising excitable tissue in order to desynchronize action potentials within the population of excitable tissue.
    Type: Application
    Filed: June 13, 2007
    Publication date: October 11, 2007
    Applicant: ADVANCED BIONICS CORPORATION
    Inventor: Edward Overstreet
  • Publication number: 20070179565
    Abstract: A multichannel cochlear implant system spatially spreads the excitation pattern in the target neural tissue by either: (1) rapid sequential stimulation of a small group of electrodes, or (2) simultaneously stimulating a small group of electrodes. Such multi-electrode stimulation stimulates a greater number of neurons in a synchronous manner, thereby increasing the amplitude of the extra-cellular voltage fluctuation and facilitating its recording. The electrical stimuli are applied simultaneously (or sequentially at a rapid rate) on selected small groups of electrodes while monitoring the evoked compound action potential (ECAP) on a nearby electrode. The presence of an observable ECAP not only validates operation of the implant device at a time when the patient may be unconscious or otherwise unable to provide subjective feedback, but also provides a way for the magnitude of the observed ECAP to be recorded as a function of the amplitude of the applied stimulus.
    Type: Application
    Filed: April 6, 2007
    Publication date: August 2, 2007
    Applicant: ADVANCED BIONICS CORPORATION
    Inventors: Edward Overstreet, Leonid Litvak, Michael Faltys
  • Publication number: 20060287609
    Abstract: Methods of automatically identifying whether a neural recording signal includes a neural response signal include fitting an artifact model to a neural recording signal to produce a fitted artifact model signal, determining a strength-of-response (SOR) metric that describes a distance of the neural recording signal from the fitted artifact model signal, and identifying the neural recording signal as including a neural response signal if the strength-of-response metric is above a pre-determined threshold.
    Type: Application
    Filed: June 1, 2005
    Publication date: December 21, 2006
    Inventors: Leonid Litvak, Edward Overstreet
  • Publication number: 20060276722
    Abstract: Methods of automatically determining a neural response threshold current level include identifying one or more neural response signals at one or more corresponding stimulation current levels, identifying one or more non-response signals at one or more corresponding stimulation current levels, and analyzing a trend between the neural response signals and the non-response signals. Systems for automatically determining a neural response threshold current level include one or more devices configured to identify one or more neural response signals at one or more corresponding stimulation current levels, identify one or more non-response signals at one or more corresponding stimulation current levels; and analyze a trend between the neural response signals and the non-response signals.
    Type: Application
    Filed: June 1, 2005
    Publication date: December 7, 2006
    Inventors: Leonid Litvak, Gulam Emadi, Edward Overstreet
  • Publication number: 20060096163
    Abstract: In the processes for treating municipal sewage and storm water containing biosolids to discharge standards, biosolids, even after dewatering, contain typically about 80% water bound in the dead cells of the biosolids, which gives biosolids a negative heating value. It can be incinerated only at the expense of purchased fuel. Biosolids are heated to a temperature at which their cell structure is destroyed and, preferably, at which carbon dioxide is split off to lower the oxygen content of the biosolids. The resulting char is not hydrophilic, and it can be efficiently dewatered and/or dried and is a viable renewable fuel. This renewable fuel can be supplemented by also charging conventional biomass (yard and crop waste, etc.) in the same or in parallel facilities. Similarly, non-renewable hydrophilic fuels can be so processed in conjunction with the processing of biosolids to further augment the energy supply.
    Type: Application
    Filed: November 7, 2005
    Publication date: May 11, 2006
    Applicant: EnerTech Environmental, Inc.
    Inventors: Norman Dickinson, Kevin Bolin, Edward Overstreet, Brian Dooley
  • Publication number: 20050245991
    Abstract: Methods and systems for modifying the parameters of at least one hearing device for a patient with residual hearing provide needed orchestration of acoustic and electric stimulation of patients wearing such devices.
    Type: Application
    Filed: March 31, 2005
    Publication date: November 3, 2005
    Inventors: Michael Faltys, Philip Segel, Edward Overstreet, William Harrison
  • Publication number: 20050182453
    Abstract: Exemplary methods of treating a patient with epilepsy include applying a stimulus to a stimulation site within the patient with an implanted system control unit in accordance with one or more stimulation parameters. The stimulus includes a stimulation current having a frequency substantially equal to or greater than 400 Hz. Exemplary systems for treating a patient with epilepsy include a system control unit configured to apply a stimulus to a stimulation site within the patient in accordance with one or more stimulation parameters. The stimulus includes a stimulation current having a frequency substantially equal to or greater than 400 Hz.
    Type: Application
    Filed: April 12, 2005
    Publication date: August 18, 2005
    Inventors: Todd Whitehurst, Edward Overstreet, Albert Maltan